Compound ID | 9
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-negative |
| Details of activity: | Topical application of OH-CATH30, either alone or in combination with LEV, is effective against drug-resistant P. aeruginosa keratitis |
| Combined with other compounds: | Yes |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China |
| Year first mentioned: | 2012 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/full/10.1128/aac.00095-14 |
| Patent: | CN109846854A |